Literature DB >> 18852248

Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.

Robert J Suchland1, Brendan M Jeffrey, Minsheng Xia, Ajay Bhatia, Hencelyn G Chu, Daniel D Rockey, Walter E Stamm.   

Abstract

Clinical isolates of Chlamydia trachomatis that lack IncA on their inclusion membrane form nonfusogenic inclusions and have been associated with milder, subclinical infections in patients. The molecular events associated with the generation of IncA-negative strains and their roles in chlamydial sexually transmitted infections are not clear. We explored the biology of the IncA-negative strains by analyzing their genomic structure, transcription, and growth characteristics in vitro and in vivo in comparison with IncA-positive C. trachomatis strains. Three clinical samples were identified that contained a mixture of IncA-positive and -negative same-serovar C. trachomatis populations, and two more such pairs were found in serial isolates from persistently infected individuals. Genomic sequence analysis of individual strains from each of two serovar-matched pairs showed that these pairs were very similar genetically. In contrast, the genome sequence of an unmatched IncA-negative strain contained over 5,000 nucleotide polymorphisms relative to the genome sequence of a serovar-matched but otherwise unlinked strain. Transcriptional analysis, in vitro culture kinetics, and animal modeling demonstrated that IncA-negative strains isolated in the presence of a serovar-matched wild-type strain are phenotypically more similar to the wild-type strain than are IncA-negative strains isolated in the absence of a serovar-matched wild-type strain. These studies support a model suggesting that a change from an IncA-positive strain to the previously described IncA-negative phenotype may involve multiple steps, the first of which involves a translational inactivation of incA, associated with subsequent unidentified steps that lead to the observed decrease in transcript level, differences in growth rate, and differences in mouse infectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852248      PMCID: PMC2583591          DOI: 10.1128/IAI.00984-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  EMBOSS: the European Molecular Biology Open Software Suite.

Authors:  P Rice; I Longden; A Bleasby
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

2.  Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.

Authors:  Benjamin Wizel; Barry C Starcher; Buka Samten; Zissis Chroneos; Peter F Barnes; John Dzuris; Yuichiro Higashimoto; Ettore Appella; Alessandro Sette
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

3.  The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion.

Authors:  T Hackstadt; M A Scidmore-Carlson; E I Shaw; E R Fischer
Journal:  Cell Microbiol       Date:  1999-09       Impact factor: 3.715

4.  A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane.

Authors:  J P Bannantine; R S Griffiths; W Viratyosin; W J Brown; D D Rockey
Journal:  Cell Microbiol       Date:  2000-02       Impact factor: 3.715

5.  Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions.

Authors:  W M Geisler; R J Suchland; D D Rockey; W E Stamm
Journal:  J Infect Dis       Date:  2001-08-22       Impact factor: 5.226

6.  Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping.

Authors:  D Dean; R J Suchland; W E Stamm
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

7.  Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane.

Authors:  R J Suchland; D D Rockey; J P Bannantine; W E Stamm
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

8.  Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes.

Authors:  R J Belland; M A Scidmore; D D Crane; D M Hogan; W Whitmire; G McClarty; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

9.  Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy non-fusogenic inclusions.

Authors:  Daniel D Rockey; Wasna Viratyosin; John P Bannantine; Robert J Suchland; Walter E Stamm
Journal:  Microbiology       Date:  2002-08       Impact factor: 2.777

10.  Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations.

Authors:  Laszlo Kari; William M Whitmire; John H Carlson; Deborah D Crane; Nathalie Reveneau; David E Nelson; David C W Mabey; Robin L Bailey; Martin J Holland; Grant McClarty; Harlan D Caldwell
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

View more
  21 in total

1.  Promoters for Chlamydia type III secretion genes show a differential response to DNA supercoiling that correlates with temporal expression pattern.

Authors:  Elizabeth Di Russo Case; Ellena M Peterson; Ming Tan
Journal:  J Bacteriol       Date:  2010-03-16       Impact factor: 3.490

Review 2.  Sequencing technologies - the next generation.

Authors:  Michael L Metzker
Journal:  Nat Rev Genet       Date:  2009-12-08       Impact factor: 53.242

3.  Complete genome sequence and annotation of the Treponema pallidum subsp. pallidum Chicago strain.

Authors:  Lorenzo Giacani; Brendan M Jeffrey; Barbara J Molini; HoaVan T Le; Sheila A Lukehart; Arturo Centurion-Lara; Daniel D Rockey
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

4.  Chlamydia Lipooligosaccharide Has Varied Direct and Indirect Roles in Evading both Innate and Adaptive Host Immune Responses.

Authors:  Xisheng Wang; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

5.  Establishing homology between mitochondrial calcium uniporters, prokaryotic magnesium channels and chlamydial IncA proteins.

Authors:  Andre Lee; Ake Vastermark; Milton H Saier
Journal:  Microbiology (Reading)       Date:  2014-05-28       Impact factor: 2.777

6.  Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.

Authors:  Gail L Sturdevant; Laszlo Kari; Donald J Gardner; Norma Olivares-Zavaleta; Linnell B Randall; William M Whitmire; John H Carlson; Morgan M Goheen; Elizabeth M Selleck; Craig Martens; Harlan D Caldwell
Journal:  Infect Immun       Date:  2010-06-14       Impact factor: 3.441

7.  Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype.

Authors:  Erika I Lutter; Christine Bonner; Martin J Holland; Robert J Suchland; Walter E Stamm; Travis J Jewett; Grant McClarty; Ted Hackstadt
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

8.  Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.

Authors:  R J Suchland; K M Sandoz; B M Jeffrey; W E Stamm; D D Rockey
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

9.  Benzylidene acylhydrazides inhibit chlamydial growth in a type III secretion- and iron chelation-independent manner.

Authors:  Xiaofeng Bao; Asa Gylfe; Gail L Sturdevant; Zheng Gong; Shuang Xu; Harlan D Caldwell; Mikael Elofsson; Huizhou Fan
Journal:  J Bacteriol       Date:  2014-06-09       Impact factor: 3.490

10.  Chromosomal Recombination Targets in Chlamydia Interspecies Lateral Gene Transfer.

Authors:  Robert J Suchland; Steven J Carrell; Yibing Wang; Kevin Hybiske; Debbie B Kim; Zoe E Dimond; P Scott Hefty; Daniel D Rockey
Journal:  J Bacteriol       Date:  2019-11-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.